[Omnix Medical in Beam Alliance] Omnix Medical Wins €10.8M In EIC Accelerator Funding
Omnix Medical, a Jerusalem-based biopharmaceutical company developing next-generation anti-infectives for the treatment of life-threatening infections, has been awarded €10.8 million in EU funding under the EIC Accelerator Programme. Read...
Read More